Cargando…

A Yes-Associated Protein (YAP) and Insulin-Like Growth Factor 1 Receptor (IGF-1R) Signaling Loop Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma

SIMPLE SUMMARY: Sorafenib is the first approved targeted therapy for the treatment of advanced hepatocellular carcinoma (HCC). However, HCC resistance to sorafenib has greatly reduced its utility. Yes-associated protein (YAP) is overexpressed in cancers, including HCC. We observed a positive correla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngo, Mai-Huong T., Peng, Sue-Wei, Kuo, Yung-Che, Lin, Chun-Yen, Wu, Ming-Heng, Chuang, Chia-Hsien, Kao, Cheng-Xiang, Jeng, Han-Yin, Lin, Gee-Way, Ling, Thai-Yen, Chang, Te-Sheng, Huang, Yen-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345119/ https://www.ncbi.nlm.nih.gov/pubmed/34359714 http://dx.doi.org/10.3390/cancers13153812

Ejemplares similares

The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance
por: Ngo, Mai-Huong Thi, et al.
Publicado: (2021)

Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma
por: Peng, Syue-Wei, et al.
Publicado: (2023)

Niche Laminin and IGF-1 Additively Coordinate the Maintenance of Oct-4 Through CD49f/IGF-1R-Hif-2α Feedforward Loop in Mouse Germline Stem Cells
por: Au, Heng-Kien, et al.
Publicado: (2021)

Endothelial Insulin and IGF-1 Receptors: When Yes Means NO
por: Muniyappa, Ranganath, et al.
Publicado: (2012)

IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma()
por: Wan, Xiaolin, et al.
Publicado: (2015)

Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome
por: Jiang, Li-Le, et al.
Publicado: (2017)

The interplay between IGF-1R signaling and Hippo-YAP in breast cancer stem cells
por: Chan, Yu-Tzu, et al.
Publicado: (2023)

JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis
por: Tomlinson, V, et al.
Publicado: (2010)

Dual roles of yes-associated protein (YAP) in colorectal cancer
por: Ou, Chunlin, et al.
Publicado: (2017)

Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis
por: Sun, Zhenqiang, et al.
Publicado: (2015)

Decreased Yes-Associated Protein-1 (YAP1) Expression in Pediatric Hearts with Ventricular Septal Defects
por: Ye, Lincai, et al.
Publicado: (2015)

A combination of sorafenib and radiotherapy reduces NF-κB activity and growth of hepatocellular carcinoma in an orthotopic mouse model
por: Chuang, Hui-Yen, et al.
Publicado: (2021)

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC
por: Chaib, Imane, et al.
Publicado: (2017)

Analysis of Yes-Associated Protein-1 (YAP1) Target Gene Signature to Predict Progressive Breast Cancer
por: Venkatasubramanian, Gomathi, et al.
Publicado: (2022)

Involvement of YAP-1, the Homolog of Yes-Associated Protein, in the Wnt-Mediated Neuronal Polarization in Caenorhabditis elegans
por: Lee, Hanee, et al.
Publicado: (2018)

Serial Low Doses of Sorafenib Enhance Therapeutic Efficacy of Adoptive T Cell Therapy in a Murine Model by Improving Tumor Microenvironment
por: Chuang, Hui-Yen, et al.
Publicado: (2014)

The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer
por: Hsu, Ping-Chih, et al.
Publicado: (2018)

Inhibition of Yes-Associated Protein-1 (YAP1) Enhances the Response of Invasive Breast Cancer Cells to the Standard Therapy
por: Guimei, Maha, et al.
Publicado: (2020)

Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts
por: Lee, Woan-Ruoh, et al.
Publicado: (2015)

A New Player in the Mechanobiology of Deep Fascia: Yes-Associated Protein (YAP)
por: Pirri, Carmelo, et al.
Publicado: (2023)

Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism
por: Shueng, Pei-Wei, et al.
Publicado: (2022)

Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway
por: Chuang, Hui-Yen, et al.
Publicado: (2019)

Yes-Associated Protein 65 (YAP) Expands Neural Progenitors and Regulates Pax3 Expression in the Neural Plate Border Zone
por: Gee, Stephen T., et al.
Publicado: (2011)

Yes-Associated Protein (Yap) Is Required for Early Embryonic Development in Zebrafish (Danio Rerio)
por: Hu, Jingying, et al.
Publicado: (2013)

Yes-Associated Protein (YAP) Modulates Oncogenic Features and Radiation Sensitivity in Endometrial Cancer
por: Tsujiura, Masahiro, et al.
Publicado: (2014)

Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells
por: Karystinou, Alexandra, et al.
Publicado: (2015)

Yes-Associated Protein (YAP) Facilitates Pressure Overload–Induced Dysfunction in the Diabetic Heart
por: Ikeda, Shohei, et al.
Publicado: (2019)

Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients
por: Molina, Eric R., et al.
Publicado: (2022)

Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study
por: Guo, Liwen, et al.
Publicado: (2020)

Yes-Associated Protein (Yap) Is Up-Regulated in Heart Failure and Promotes Cardiac Fibroblast Proliferation
por: Sharifi-Sanjani, Maryam, et al.
Publicado: (2021)

IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2020)

Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis
por: Marquard, Simone, et al.
Publicado: (2020)

The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients
por: Cha, Yoon Jin, et al.
Publicado: (2021)

The feedback loop of ANKHD1/lncRNA MALAT1/YAP1 strengthens the radioresistance of CRC by activating YAP1/AKT signaling
por: Yao, Ping-an, et al.
Publicado: (2022)

Retinal blood vessel‐origin yes‐associated protein (YAP) governs astrocytic maturation via leukaemia inhibitory factor (LIF)
por: Ai, Li‐Qian‐Yu, et al.
Publicado: (2020)

The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1
por: Pilgrim, Adeiye A., et al.
Publicado: (2023)

Yes-Associated Protein (YAP) Promotes Tumorigenesis in Melanoma Cells Through Stimulation of Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1)
por: Xiong, Huizi, et al.
Publicado: (2017)

Yes-Associated Protein (Yap) Is Necessary for Ciliogenesis and Morphogenesis during Pronephros Development in Zebrafish (Danio Rerio)
por: He, Liangliang, et al.
Publicado: (2015)

Curcumin Induces Autophagy via Inhibition of Yes-Associated Protein (YAP) in Human Colon Cancer Cells
por: Zhu, Jing, et al.
Publicado: (2018)

CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
por: Chen, Zibo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ssjh37de24u83u7eo96sc3e1c8